Authors

    Language

    English

    Publication Date

    1-1-2022

    Journal

    Frontiers in Global Women's Health

    DOI

    10.3389/fgwh.2022.856316

    PMID

    35449709

    PMCID

    PMC9016174

    PubMedCentral® Posted Date

    4-5-2022

    PubMedCentral® Full Text Version

    Post-print

    Abstract

    Endometriosis is a known estrogen-dependent inflammatory disease affecting reproductive-aged women. Common symptoms include pelvic pain, dysmenorrhea, dyspareunia, heavy menstrual bleeding, and infertility. The exact etiology of endometriosis is largely unknown, and, thus, the diagnosis and treatment of endometriosis are challenging. A complex interplay of many molecular mechanisms is thought to aid in the progression of endometriosis, most notably angiogenesis. This mini-review examines our current knowledge of the molecular etiology of endometriosis-associated angiogenesis and discusses anti-angiogenic therapy, in the blockade of endometriosis-associated angiogenesis, as potential non-hormonal therapy for the treatment of endometriosis.

    Keywords

    endometriosis, angiogenesis, estrogen receptors, vascular endothelial growth factor, anti-angiogenic therapy

    Published Open-Access

    yes

    Share

    COinS
     
     

    To view the content in your browser, please download Adobe Reader or, alternately,
    you may Download the file to your hard drive.

    NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.